Triple
T12544153
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Yamanaka factors |
E299917
|
entity |
| Predicate | firstPublicationTitle |
P17945
|
FINISHED |
| Object | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors |
E299917
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Statement: [Yamanaka factors, firstPublicationTitle, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Context triple: [Yamanaka factors, firstPublicationTitle, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors]
-
A.
Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc
Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc are a set of transcription factors whose forced expression can reprogram differentiated somatic cells into induced pluripotent stem cells.
-
B.
Yamanaka factors
chosen
Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
-
C.
eGenesis
eGenesis is a biotechnology company focused on using advanced gene-editing technologies to make animal organs safe and suitable for human transplantation.
-
D.
Committee on Development, Regeneration and Stem Cell Biology
The Committee on Development, Regeneration and Stem Cell Biology is an academic program at the University of Chicago focused on research and graduate training in developmental biology, tissue regeneration, and stem cell science.
-
E.
A Genetic Switch: Phage Lambda and Higher Organisms
"A Genetic Switch: Phage Lambda and Higher Organisms" is a seminal molecular biology book that explains how gene regulation in bacteriophage lambda illuminates fundamental mechanisms of genetic control in more complex organisms.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6ada707008190aaec1238117c9379 |
completed | April 8, 2026, 7:33 p.m. |
| NER | Named-entity recognition | batch_69d9547d6df4819080db8415d386ed38 |
completed | April 10, 2026, 7:50 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f655801cac8190b1f9a72f8fed0399 |
completed | May 2, 2026, 7:50 p.m. |
Created at: April 8, 2026, 9:57 p.m.